Serological Studies of West Nile Virus in a Liver Transplant Population

Simple item page
dc.contributor.authorNicolle, LE
dc.contributor.authorGutkin, A
dc.contributor.authorSmart, G
dc.contributor.authorDawood, M
dc.contributor.authorDrebot, M
dc.contributor.authorVan Caeseele, P
dc.contributor.authorGiulivi, A
dc.contributor.authorMinuk, GY
dc.date.accessioned2016-06-08T17:56:52Z
dc.date.available2016-06-08T17:56:52Z
dc.date.issued2004-1-1
dc.date.updated2016-06-07T06:59:47Z
dc.description.abstractBACKGROUND: Solid organ transplant populations are at increased risk for serious clinical manifestations of West Nile virus (WNV) infection.OBJECTIVE: To monitor liver transplant recipients during the 2003 WNV season in Manitoba and to identify incidence, clinical presentation and serology.METHODS: Serial blood specimens were obtained from adult patients followed at the liver transplant outpatient clinic between May 2003 and October 2003. Studies for WNV infection included immunoglobulin (Ig) G and IgM enzyme immunoassay (EIA), hemagglutination inhibition (HI), plaque reduction neutralization test and reverse transcriptase-polymerase chain reaction.RESULTS: None of the 79 patients had clinical presentations suggestive of WNV infection. On testing of the final serum specimen obtained, 14 patients (18%) had positive IgG anti-WNV by EIA and six patients (7%) had indeterminate IgG anti-WNV by EIA, although all were negative by IgM EIA. Four (20%) of the EIA-positive samples were reactive by HI, but all of these were negative by WNV plaque reduction neutralization test; this is consistent with the presence of non-West Nile flavivirus antibody in these sera. Blood specimens obtained throughout the season from EIA- and HI-positive individuals were uniformly negative for WNV-RNA by reverse transcriptase- polymerase chain reaction. Age, sex, hematology and biochemistry findings, hepatitis B or C virus status, immunosuppressive regimen (cyclosporin or tacrolimus) and pretransplant diagnosis of liver disease were similar for EIA-positive and EIA-negative patients. For the 10 patients with a positive IgG EIA maintained on cyclosporin, the cyclosporin level was 129.1±28.6 µg/L compared with 85.6±36.7 µg/L in 26 patients who were EIA-negative (P=0.002).CONCLUSIONS: False-positive IgG EIA serology for WNV was common in this cohort of liver transplant recipients, and was associated with elevated serum cyclosporin levels.
dc.description.versionPeer Reviewed
dc.identifier.citationLE Nicolle, A Gutkin, G Smart, et al., “Serological Studies of West Nile Virus in a Liver Transplant Population,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 15, no. 5, pp. 271-274, 2004. doi:10.1155/2004/606015
dc.identifier.urihttp://dx.doi.org/10.1155/2004/606015
dc.identifier.urihttp://hdl.handle.net/1993/31418
dc.language.rfc3066en
dc.rightsopen accessen_US
dc.rights.holderCopyright © 2004 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.titleSerological Studies of West Nile Virus in a Liver Transplant Population
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
CJIDMM.2004.606015.xml
Size:
7.21 KB
Format:
Extensible Markup Language
Description:
Download
Thumbnail Image
Name:
CJIDMM.2004.606015.pdf
Size:
172.78 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.24 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
University of Manitoba Scholarship
Rady Faculty of Health Sciences Scholarly Works